Fasting lipid profile and apolipoprotein-E phenotype in HIV infected patients with type III dyslipidaemia taking protease inhibitors
| Patient | Age | Sex | PI | Time on PI (weeks) | Total cholesterol (mmol/l) | HDL cholesterol (mmol/l) | Triglyceride (mmol/l) | Lipoprotein-(a) (mg/l) | Phenotype | Lipodystrophy |
|---|---|---|---|---|---|---|---|---|---|---|
| I = indinavir, N = nelfinavir, R = ritonavir, S = saquinavir. | ||||||||||
| *Electrophoresis was not carried out before therapy. | ||||||||||
| †Had ritonavir for 7 and nelfinavir for 12 months. | ||||||||||
| AB | 33 | M | I | 60 | 7.1 | 0.8 | 9.1 | 747 | E2/E2 | Yes |
| PC | 37 | M | N | 13 | 11 | 0.4 | 23 | 236 | E3/E3 | No |
| JE* | 37 | F | R | 5 | 11 | 0.8 | 12 | 306 | E3/E2 | Yes |
| RF | 50 | M | I | 16 | 15.2 | 0.7 | 27 | 62 | E3/E3 | Yes |
| CF | 40 | M | R | 25 | 8.2 | 0.8 | 7.9 | 192 | E4/E3 | Yes |
| JG | 31 | M | R | 17 | 9.3 | 0.7 | 9.6 | 237 | E4/E3 | No |
| ML | 31 | M | R | 24 | 10.2 | 0.9 | 5.4 | 147 | E3/E3 | No |
| TP | 39 | M | N† | 76 | 6.8 | 0.8 | 7.8 | 184 | E4/E2 | Yes |
| GR | 44 | M | R/S | 26 | 8.7 | 0.5 | 12 | 192 | E3/E3 | Yes |
| AR | 34 | M | R | 25 | 8.9 | 0.9 | 11 | 417 | E3/E3 | No |
| CW | 43 | M | R/S | 29 | 8.4 | 1 | 10.6 | 198 | E3/E3 | Yes |
| MW | 50 | M | R | 26 | 13.2 | 0.8 | 18 | 501 | E3/E2 | Yes |